Company intelligence / Profile preview

AAT Bioquest

Pleasanton, California, United Statesaatbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

AAT Bioquest develops and supplies over 5,000 bioanalytical reagents and kits—including fluorescent/luminescent probes, antibodies, enzyme substrates, cell viability assays—used globally by researchers in life sciences, diagnostics R&D, and drug discovery. Their products enable advanced photometric detection using colorimetric, fluorimetric and luminescent technologies. They do not have clinical results as they do not develop drugs or diagnostics themselves.

Modalities: Small molecule (as chemical probes and dyes)Protein (antibodies, enzymes)Peptides (substrates for assays)Device (assay kits as research tools)
Industry: Chemicals & Materials

Partnerships

None publicly listed; distributes through global distributor network.

Beyond the preview

Go deeper on AAT Bioquest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAT Bioquest.